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28.
In early methods for the enzymatic determination of urinary oxalate, the oxalate oxidase had to be prepared in the laboratory (1-3), generally a difficult and lengthy procedure with little appeal to a busy laboratory. When oxalate oxidase became commercially available (Boehringer Mannheim), we decided to assessthe method of Laker et al. (2) for determination of urinary oxalate. In this method, interfering substances in urine are removed by ion-exchange resin in a column, and the effluent containing the oxalate is measured via MBTH and DMA to form the indamine dye. This chromatography step is somewhat tedious, especially forbatch analyses.
We attempted to measure oxalate directly, without resin 
Materials and Methods
Reagents
Maximum oxalate concentration
is reached at about 20-fold dilution, the dilution we recommend for our method.
Analytical-recovery studies on five urines containing oxalate ranging from 0.4 to 2.0 mmol/L (n = 3 each) showed a mean recovery of 99% (range 92-109%). Urine used in the recovery experiment should be acidified and aged for at least one day; for reasons unknown, we obtained poor recoveries forfreshurines.
Results of within-day and between-day precision studies are detailed in Table 1 . 
Discussion
The availability of a commercial oxalate oxidase ensures a constant supply of standardized enzyme preparations and overcomes the problem of different batches of enzyme affecting the color development (2) . We have used three batches of oxalate oxidase without problems. If the stock oxalate oxidase solution is stored at -20 #{176}C, the enzyme is stable for long periods.
A major problem encountered in using oxalate oxidase is interference. Chinboga (5), using partly purified oxalate oxidase, showed that this enzyme was activated by flavins and some chelating agents. Fluoride and iodoacetate inhibited the enzyme. The effect of divalent metals varied, but calcium and copper ions inhibited the enzyme activity. To guard against drug interference in the assay, Laker et al. (2) suggested individual test blanks. Thus each urine sample had its own blank in which oxalate oxidase was omitted in the assay. We observed that such blanks had absorbances lower than the reagent blank that has the oxalate oxidase. Because the oxalate oxidase apparently contributes to the formation of some color in the reaction, when compared with the blanks without oxalate oxidase, individual urine blanks without oxalate oxidase are therefore inappropriate.
Contrary Urine in particular may contain interfering substances.
We found it necessary to pre-treat urine samples with charcoal. If not, the oxalate oxidase was inhibited and the indaniine dye colorwas either partly or completely suppressed. For the aqueous oxalate standard, pre-treatment with charcoal was unnecessary. This suggests that charcoal removes inhibitors from urine, but only when the urine is first diluted 20-foldand alkalinized. At lesser dilutions, the inhibitionis not completely removed (Figure 1) . In a recently described method(6) involvingimmobilized oxalate oxidase and a continuous-flow system, urinary oxalate had to be precipitated before being measured, to overcome inhibition.
For a very concentrated urine, a 20-fold dilution may not completely overcome the inhibition. We recommend setting up another tube for a 40-fold dilution by adding 0.05 mL of urine to 1.95 mL of water.
Glycosuria introduces a small positive interference.
The apparent increase in urine oxalate at a glucose concentration of 50 and 100 mmol/L (approximately + + + and + + + + with Ames' Keto-diastix) is 0.12 and 0.20 mmol/L, respectively.
We have not encountered any interference with the urines in our oxalate assay. One quality-control urine specimen, however, immediately became blue when the color reagent was added to the charcoal-treated supernate, even when the oxalate oxidase was omitted. After appropriate correction for this blank absorbance, the calculated oxalate agreed well with the chemical assay. This is probably fortuitous, however, and we cannot recommend this as a correction procedure. We have not been abletoidentif' the interfering substance in the quality-control urine, but con-
